Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Lenabasum in Diffuse Cutaneous Systemic Sclerosis
jRCT2080223985Phase 3Completed
- Sponsor
- Corbus Pharmaceuticals Holdings, Inc.
- Start
- Jul 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of lenabasum in systemic sclerosis (SSc) (3 arms), sponsored by Corbus Pharmaceuticals Holdings, Inc. Started Jul 2018; status: completed.
02
Drugs
lenabasum
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on jRCT2080223985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223985.